Alife Receives FDA Clearance for Embryo Predict Read More
Trusted by Fertility Leaders
Our Platform
An ecosystem of products designed to empower every member of the clinic
Embryo Predict
Give your lab consistent and objective AI embryo scoring to aid in every transfer decision
Learn more
Schedule Predict
Reduce over capacity retrieval days by up to 65%, lowering operating cost and increasing efficiency
Learn more
Success Predictor
Increase patient conversion by greater than 3% and improve patient satisfaction
Learn more
Scientific Publications
Supported by peer-reviewed research
Scientific Abstract
Fertility and Sterility
Evaluation of artificial intelligence for embryo selection during IVF: A prospective, randomized controller trial
Read more
Journal Publication
Fertility and Sterility
Study finds that AI model may help optimize ovulation trigger injection timing to improve outcomes for IVF patients
Read more
Journal Publication
RBMO
Study shows that mature oocytes, fertilized oocytes, and usable blastocysts increased in patients who received an optimal dose of FSH
Read more
Scientific abstract
Fertility and Sterility
Study shows interpretable machine learning model non-inferior to embryologists in selecting best embryo for IVF transfer
Read more
Why IVF clinics like yours choose Alife
"We’ve seen first-hand how Alife’s state-of-the-art, direct-to-patient embryo vitrification reporting boosts operational efficiencies and elevates patient experience."
Kate Devine, MD
Medical Director and Chief Research Officer of US Fertility
“Not only have we seen an improvement in laboratory record organization, the improvement in efficiencies has made for a more seamless workflow experience.”
Matthew “Tex” VerMilyea, PhD, HCLD/CC
VP of Scientific Advancement at Ovation Fertility
“Since incorporating Stim Assist into my practice I have been able to use less medication and obtain more mature eggs.”
Brad Miller, MD
Reproductive Endocrinologist, Reproductive Medicine Associates of Michigan
“It is easy to use and the customer service response with the team is excellent.”
Jordan Clarke, MS
Embryologist, Ovation Fertility
Embryo Predict is now available across the U.S. and Europe
Connect with one of our AI experts to learn how you can optimize your clinic with Alife.
*Embryo Predict is indicated to analyze images of Day 5, 6, and 7 blastocyst-stage embryos that have been deemed suitable for transfer by the embryologist. The device provides adjunctive information to aid in the assessment of blastocysts when there are multiple embryos deemed suitable for transfer or freezing based on standard morphological assessment.
Sign up for our newsletter for the latest advancements in fertility care.
©2026 by Alife Health
Terms
Privacy
App Privacy
Security
Cookie Declaration
[website version: 740-00200-REC-01 Rev 2]
